Prism Medico Pharmacy Ltd vs State Trading Corporation Of India Ltd Stock Comparison
Prism Medico Pharmacy Ltd vs State Trading Corporation Of India Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 35.05 as of 30 Oct 15:30
. The P/E Ratio of Prism Medico & Pharmacy Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of State Trading Corporation of India Ltd changed from 12.9 on March 2023 to 31 on March 2025 . This represents a CAGR of 33.94% over 3 years The Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of State Trading Corporation of India Ltd changed from ₹ 445.8 crore on March 2021 to ₹ 765.3 crore on March 2025 . This represents a CAGR of 11.41% over 5 years The revenue of Prism Medico & Pharmacy Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of State Trading Corporation of India Ltd for the Mar '26 is ₹ 25.64 crore as compare to the Dec '25 revenue of ₹ 24.86 crore. This represent the growth of 3.14% The ebitda of Prism Medico & Pharmacy Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of State Trading Corporation of India Ltd for the Mar '26 is ₹ 13.93 crore as compare to the Dec '25 ebitda of ₹ 14.72 crore. This represent the decline of -5.37% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0%
The net profit of State Trading Corporation of India Ltd changed from ₹ 27.45 crore to ₹ 9.77 crore over 8 quarters. This represents a CAGR of -40.34%
The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of State Trading Corporation of India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Prism Medico & Pharmacy Ltd
Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities.
Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading.
During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.
About State Trading Corporation of India Ltd
The State Trading Corporation of India Limited (STC) is a premier International trading company of the Government of India, and, was engaged primarily in exports, and imports operations.
The Corporation was set up in 1956 primarily with a view to undertake trade with East European Countries and to supplement the efforts of private trade and industry in developing exports from the country.
The Corporation is registered as an autonomous company under the Companies Act, 1956 and functions under the administrative control of the Ministry of Commerce & Industry, Govt. of India.
The Corporation has played a key role in the Indian economy.
In the pre-liberalisation era, it acted as an arm of the Government of India not only to regulate foreign trade but also for intervention in the domestic market.
FAQs for the comparison of Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd
Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or State Trading Corporation of India Ltd?
Market cap of Prism Medico & Pharmacy Ltd is 47 Cr while Market cap of State Trading Corporation of India Ltd is 589 Cr
What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd?
The stock performance of Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd?
As of November 1, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹35.05. On the other hand, State Trading Corporation of India Ltd stock price is INR ₹98.2.
How do dividend payouts of Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd compare?
To compare the dividend payouts of Prism Medico & Pharmacy Ltd and State Trading Corporation of India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.